Home > Income Statement > ALEMBIC PHARMACEUTICALS

ALEMBIC PHARMACEUTICALS
Revenue

    Back to Income Statement
ALEMBIC PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for ALEMBIC PHARMACEUTICALS
Please provide your vote to see the results

ALEMBIC PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹7,345 Cr₹6,672 Cr₹6,229 Cr₹5,653 Cr₹5,306 Cr

What is the latest Revenue of ALEMBIC PHARMACEUTICALS ?

The latest Revenue ratio of ALEMBIC PHARMACEUTICALS is ₹7,345 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹7,345 Cr
Mar2025₹6,672 Cr
Mar2024₹6,229 Cr
Mar2023₹5,653 Cr
Mar2022₹5,306 Cr

How is Revenue of ALEMBIC PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2026 ₹7,345 Cr
10.08
Mar2025 ₹6,672 Cr
7.12
Mar2024 ₹6,229 Cr
10.19
Mar2023 ₹5,653 Cr
6.54
Mar2022 ₹5,306 Cr -

Compare Revenue of peers of ALEMBIC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ALEMBIC PHARMACEUTICALS ₹15,684.7 Cr 4% -7.2% -13.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,662.0 Cr 2% -4.4% 3.7% Stock Analytics
DIVIS LABORATORIES ₹257,903.0 Cr 7.1% 2.5% 46.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,306.0 Cr 1.4% -5.7% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹112,699.0 Cr 3.6% 8% 4.2% Stock Analytics
CIPLA ₹111,489.0 Cr 2% -0.2% -14.3% Stock Analytics


ALEMBIC PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ALEMBIC PHARMACEUTICALS

4%

-7.2%

-13.9%

SENSEX

1.8%

2.3%

-11.9%


You may also like the below Video Courses